AstraZeneca's Alexion loses $130M to Syntimmune shareholders in post-merger payment suit

9th September 2024 Uncategorised 0

AstraZeneca’s Alexion loses $130M to Syntimmune shareholders in post-merger payment suit
zbecker
Mon, 09/09/2024 – 11:14

More: AstraZeneca's Alexion loses 0M to Syntimmune shareholders in post-merger payment suit
Source: fierce